Vontobel Holding Ltd. Intellia Therapeutics, Inc. Transaction History

Vontobel Holding Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$38.49 - $76.21 $472,041 - $934,639	-12,264 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $100,923 - $206,090	-1,732 Reduced 12.37%	12,264 $885,000
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $1.04 Million - $1.42 Million	10,296 Added 278.27%	13,996 $1.66 Million
Q3 2021 Oct 29, 2021	BUY	$132.37 - $176.78 $489,769 - $654,086	3,700 New	3,700 $496,000

333

90.3M

537K

818K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $733M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.